Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Receivables (2024)

Zentalis Pharmaceuticals (ZNTL) has 1 years of Receivables data on record, last reported at $5.0 million in Q4 2024.

  • For Q4 2024, Receivables changed N/A year-over-year to $5.0 million; the TTM value through Dec 2024 reached $5.0 million, changed N/A, while the annual FY2024 figure was $5.0 million, N/A changed from the prior year.
  • Receivables reached $5.0 million in Q4 2024 per ZNTL's latest filing.
  • Across five years, Receivables topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.